Related Experiment Video
Updated: Jul 1, 2025
10:20
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
8.5K
Structural Basis for Molecular Recognition of Cannabinoids by Inhibitory Cys-Loop Channels
Lautaro D Alvarez1,2, N R Carina Alves1,2
1Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires C1428EGA, Argentina.
Journal of Medicinal Chemistry
|March 1, 2024
Summary
Cannabis compounds, known as cannabinoids, interact with human inhibitory channels like glycine receptors (GlyR). This study identifies cannabinoid binding sites on these crucial nervous system targets.
Area of Science:
- Neuroscience
- Pharmacology
- Structural Biology
Background:
- Cannabis sativa has a long history of medicinal use.
- Cannabinoids interact with human Cys-loop receptors, including glycine receptors (GlyR) and GABAA receptors (GABAAR).
- These receptors are key mediators of inhibitory signals in the nervous system, influencing cannabinoid effects.
Purpose of the Study:
- To identify the precise location of cannabinoid binding sites within the transmembrane domain of inhibitory channels.
- To analyze computational approaches used for identifying these binding sites.
- To guide future research on the molecular mechanisms of cannabinoid action.
Main Methods:
- Analysis of recently resolved cryo-electron microscopy (cryo-EM) structures of zebrafish GlyR.
- Examination of the Δ9-tetrahydrocannabinol (THC)-GlyR complex.
- Molecular dynamics simulations to study the THC-GlyR complex.
Main Results:
- Provided insights into the binding site of cannabinoids within the transmembrane domain of GlyR.
- Utilized cryo-EM and molecular dynamics to visualize the interaction between THC and GlyR.
- Detailed the computational strategies employed for site identification.
Conclusions:
- The study contributes to understanding the molecular basis of cannabinoid action on inhibitory channels.
- Identified specific binding locations for cannabinoids on GlyR.
- Offers a foundation for future investigations into cannabinoid-glycine receptor interactions.
More Related Videos
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:19Ligand-gated Ion Channels
12.4K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.4K
01:22Opioid Receptors: Overview
808
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
808
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
277
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
277
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
193
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
193
01:29The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K